These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22109743)

  • 1. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
    Desjardins L; Liabeuf S; Renard C; Lenglet A; Lemke HD; Choukroun G; Drueke TB; Massy ZA;
    Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
    Kim CS; Bae EH; Ma SK; Han SH; Lee KB; Lee J; Oh KH; Chae DW; Kim SW;
    J Korean Med Sci; 2017 Feb; 32(2):240-248. PubMed ID: 28049234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND;
    Am J Nephrol; 2020; 51(3):201-215. PubMed ID: 32023606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
    Desbiens LC; Sidibé A; Ung RV; Fortier C; Munger M; Wang YP; Bisson SK; Marquis K; Agharazii M; Mac-Way F
    Osteoporos Int; 2018 Oct; 29(10):2345-2353. PubMed ID: 29959497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
    Scialla JJ; Lau WL; Reilly MP; Isakova T; Yang HY; Crouthamel MH; Chavkin NW; Rahman M; Wahl P; Amaral AP; Hamano T; Master SR; Nessel L; Chai B; Xie D; Kallem RR; Chen J; Lash JP; Kusek JW; Budoff MJ; Giachelli CM; Wolf M;
    Kidney Int; 2013 Jun; 83(6):1159-68. PubMed ID: 23389416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
    Pelletier S; Confavreux CB; Haesebaert J; Guebre-Egziabher F; Bacchetta J; Carlier MC; Chardon L; Laville M; Chapurlat R; London GM; Lafage-Proust MH; Fouque D
    Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
    Jovanovich A; Isakova T; Block G; Stubbs J; Smits G; Chonchol M; Miyazaki M
    Am J Kidney Dis; 2018 Jan; 71(1):27-34. PubMed ID: 28801122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
    El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
    Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).
    Toussaint ND; Pedagogos E; Lioufas NM; Elder GJ; Pascoe EM; Badve SV; Valks A; Block GA; Boudville N; Cameron JD; Campbell KL; Chen SSM; Faull RJ; Holt SG; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Hooi LS; Narayan O; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Hawley CM;
    J Am Soc Nephrol; 2020 Nov; 31(11):2653-2666. PubMed ID: 32917784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart.
    Ford ML; Smith ER; Tomlinson LA; Chatterjee PK; Rajkumar C; Holt SG
    Nephrol Dial Transplant; 2012 Feb; 27(2):727-33. PubMed ID: 21750158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis.
    Aleksova J; Kurniawan S; Vucak-Dzumhur M; Kerr P; Ebeling PR; Milat F; Elder GJ
    Bone; 2018 Aug; 113():118-123. PubMed ID: 29775762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease.
    Salam S; Gallagher O; Gossiel F; Paggiosi M; Eastell R; Khwaja A
    Bone; 2021 Feb; 143():115699. PubMed ID: 33091638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease.
    Temmar M; Liabeuf S; Renard C; Czernichow S; Esper NE; Shahapuni I; Presne C; Makdassi R; Andrejak M; Tribouilloy C; Galan P; Safar ME; Choukroun G; Massy Z
    J Hypertens; 2010 Jan; 28(1):163-9. PubMed ID: 19927012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients.
    Lee YT; Ng HY; Chiu TT; Li LC; Pei SN; Kuo WH; Lee CT
    Clin Chim Acta; 2016 Jan; 452():38-43. PubMed ID: 26522655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study.
    Schoppet M; Hofbauer LC; Brinskelle-Schmal N; Varennes A; Goudable J; Richard M; Hawa G; Chapurlat R; Szulc P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E575-83. PubMed ID: 22319041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic toxicity and sclerostin in chronic kidney disease patients.
    Desjardins L; Liabeuf S; Oliveira RB; Louvet L; Kamel S; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
    Nephrol Ther; 2014 Nov; 10(6):463-70. PubMed ID: 25070604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3-5D.
    Zhang M; Yan J; Zhu M; Ni Z
    Ann Clin Lab Sci; 2015; 45(1):17-22. PubMed ID: 25696005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.